4-bromo-5-methyl-1H-pyrazole;2-(4-bromo-3-methylpyrazol-1-yl)-5-methyl-1,3-thiazole;2-bromo-5-methyl-1,3-thiazole;2,6-difluorobenzoyl chloride;2,6-difluoro-N-[5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]-2-pyridinyl]benzamide;bis(5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]pyridin-2-amine);5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
C80H78BBr3ClF4N23O4S5 — CID 158826108
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-bromo-5-methyl-1H-pyrazole;2-(4-bromo-3-methylpyrazol-1-yl)-5-methyl-1,3-thiazole;2-bromo-5-methyl-1,3-thiazole;2,6-difluorobenzoyl chloride;2,6-difluoro-N-[5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]-2-pyridinyl]benzamide;bis(5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]pyridin-2-amine);5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
4-bromo-5-methyl-1H-pyrazole;2-(4-bromo-3-methylpyrazol-1-yl)-5-methyl-1,3-thiazole;2-bromo-5-methyl-1,3-thiazole;2,6-difluorobenzoyl chloride;2,6-difluoro-N-[5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]-2-pyridinyl]benzamide;bis(5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]pyridin-2-amine);5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine (PubChem CID 158826108) has the molecular formula C80H78BBr3ClF4N23O4S5 and a molecular weight of 1947.96 g/mol. Its IUPAC name is 4-bromo-5-methyl-1H-pyrazole;2-(4-bromo-3-methylpyrazol-1-yl)-5-methyl-1,3-thiazole;2-bromo-5-methyl-1,3-thiazole;2,6-difluorobenzoyl chloride;2,6-difluoro-N-[5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]-2-pyridinyl]benzamide;bis(5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]pyridin-2-amine);5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine.
Molecular Properties
| Compound Name | 4-bromo-5-methyl-1H-pyrazole;2-(4-bromo-3-methylpyrazol-1-yl)-5-methyl-1,3-thiazole;2-bromo-5-methyl-1,3-thiazole;2,6-difluorobenzoyl chloride;2,6-difluoro-N-[5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]-2-pyridinyl]benzamide;bis(5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]pyridin-2-amine);5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine |
|---|---|
| PubChem CID | 158826108 |
| Molecular Formula | C80H78BBr3ClF4N23O4S5 |
| Molecular Weight | 1947.96 g/mol |
| Exact Mass | 1943.25 |
| IUPAC Name | 4-bromo-5-methyl-1H-pyrazole;2-(4-bromo-3-methylpyrazol-1-yl)-5-methyl-1,3-thiazole;2-bromo-5-methyl-1,3-thiazole;2,6-difluorobenzoyl chloride;2,6-difluoro-N-[5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]-2-pyridinyl]benzamide;bis(5-[3-methyl-1-(5-methyl-1,3-thiazol-2-yl)pyrazol-4-yl]pyridin-2-amine);5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine |
| SMILES | CC1(C)OB(c2ccc(N)nc2)OC1(C)C.Cc1[nH]ncc1Br.Cc1cnc(-n2cc(-c3ccc(N)nc3)c(C)n2)s1.Cc1cnc(-n2cc(-c3ccc(N)nc3)c(C)n2)s1.Cc1cnc(-n2cc(-c3ccc(NC(=O)c4c(F)cccc4F)nc3)c(C)n2)s1.Cc1cnc(-n2cc(Br)c(C)n2)s1.Cc1cnc(Br)s1.O=C(Cl)c1c(F)cccc1F |
| InChI | InChI=1S/C20H15F2N5OS.2C13H13N5S.C11H17BN2O2.C8H8BrN3S.C7H3ClF2O.C4H5BrN2.C4H4BrNS/c1-11-8-24-20(29-11)27-10-14(12(2)26-27)13-6-7-17(23-9-13)25-19(28)18-15(21)4-3-5-16(18)22;2*1-8-5-16-13(19-8)18-7-11(9(2)17-18)10-3-4-12(14)15-6-10;1-10(2)11(3,4)16-12(15-10)8-5-6-9(13)14-7-8;1-5-3-10-8(13-5)12-4-7(9)6(2)11-12;8-7(11)6-4(9)2-1-3-5(6)10;1-3-4(5)2-6-7-3;1-3-2-6-4(5)7-3/h3-10H,1-2H3,(H,23,25,28);2*3-7H,1-2H3,(H2,14,15);5-7H,1-4H3,(H2,13,14);3-4H,1-2H3;1-3H;2H,1H3,(H,6,7);2H,1H3 |
| InChIKey | IWMAFQWCKUYKJY-UHFFFAOYSA-N |
| XLogP | 19.43 |
| TPSA | 358.66 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 121 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1947.96 |
| LogP ≤ 5 | 19.43 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 30 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'acid_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158826108 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.